3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
22 22 0 0 0 0 0 0 0999 V2000
-1.7533 -2.8487 0.2213 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.5375 0.8114 0.0712 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7037 1.4042 -0.0553 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0365 -0.8926 0.1395 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3647 -0.3263 0.0107 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9869 1.9260 -0.1786 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6406 -0.1185 0.1810 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9009 -0.7615 -1.1750 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8710 0.6204 0.6903 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2088 0.4248 0.0513 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9689 0.9544 -0.0693 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3448 -1.1937 0.1129 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4087 -0.9012 0.9143 H 1 0 0 0 0 0 0 0 0 0 0 0
1.7293 1.8000 -0.0452 H 0 0 0 0 0 0 0 0 0 0 0 0
3.1242 -0.0057 -1.9368 H 1 0 0 0 0 0 0 0 0 0 0 0
2.0379 -1.3358 -1.5267 H 1 0 0 0 0 0 0 0 0 0 0 0
3.7534 -1.4470 -1.1208 H 1 0 0 0 0 0 0 0 0 0 0 0
4.1706 1.4205 0.0038 H 1 0 0 0 0 0 0 0 0 0 0 0
3.6739 1.0794 1.6654 H 1 0 0 0 0 0 0 0 0 0 0 0
4.7184 -0.0638 0.8039 H 1 0 0 0 0 0 0 0 0 0 0 0
-2.7368 2.9032 -0.2413 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.9541 1.6333 -0.1928 H 0 0 0 0 0 0 0 0 0 0 0 0
1 12 1 0 0 0 0
2 7 1 0 0 0 0
2 10 1 0 0 0 0
2 14 1 0 0 0 0
3 10 1 0 0 0 0
3 11 2 0 0 0 0
4 10 2 0 0 0 0
4 12 1 0 0 0 0
5 11 1 0 0 0 0
5 12 2 0 0 0 0
6 11 1 0 0 0 0
6 21 1 0 0 0 0
6 22 1 0 0 0 0
7 8 1 0 0 0 0
7 9 1 0 0 0 0
7 13 1 0 0 0 0
8 15 1 0 0 0 0
8 16 1 0 0 0 0
8 17 1 0 0 0 0
9 18 1 0 0 0 0
9 19 1 0 0 0 0
9 20 1 0 0 0 0
M ISO 7 13 2 15 2 16 2 17 2 18 2 19 2 20 2
4. 国际命名与标识
4.1 IUPAC Name
6-chloro-2-N-(1,1,1,2,3,3,3-heptadeuteriopropan-2-yl)-1,3,5-triazine-2,4-diamine
4.2 InChl
InChI=1S/C6H10ClN5/c1-3(2)9-6-11-4(7)10-5(8)12-6/h3H,1-2H3,(H3,8,9,10,11,12)/i1D3,2D3,3D
4.3 InChlKey
DFWFIQKMSFGDCQ-YYWVXINBSA-N
4.4 Canonical SMILES
CC(C)NC1=NC(=NC(=N1)N)Cl
4.5 lsomeric SMILES
[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])NC1=NC(=NC(=N1)N)Cl
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病